eNews July 14, 2020

The latest news affecting you and your customers… from the Independent Medical Specialty Dealers Association

How is COVID-19 affecting your business, your people, your customers? IMDA is a membership organization, and in times like these, we can all use some camaraderie. If you have a COVID story to share, advice to offer, or a warning to sound, send it to Mark Thill, IMDA’s communications director, at mdthill1913@gmail.com, with the subject line “IMDA COVID story.” We’ll compile them and send them back out to you.

Not just in time

COVID-19 will force hospitals to rethink the “just-in-time” supply chain strategies that led to shortages of needed supplies during the pandemic, Mayo Clinic’s CEO said at an event sponsored by Fortune magazine earlier this month, reports Fierce Healthcare. “We failed when it came to understanding how fragmented our system was and, of course, the strange way we pay for healthcare,” Mayo Clinic President and CEO Gianrico Farrugia, M.D., was quoted as saying. Mayo has learned that while a just-in-time supply chain works well for other companies, it doesn’t work for healthcare under a pandemic, he said.

What happens to elective surgeries?

Unlike three months ago, when most hospitals suspended elective surgeries due to COVID-19, many hospitals today are offering such surgeries despite rising numbers of COVID-19 cases across the country, reports Kaiser Health News. Hospitals say they are more prepared to handle the crush of patients than they were this spring because they have enough protective gear for their workers and they know how to better treat coronavirus patients. They will shut down nonessential procedures at hospitals based on local assessments of risk — but not across entire systems or states. Hospitals’ decisions to keep operating rooms open are being guided partly by money. Elective surgeries account for a significant portion of hospital revenue, and the American Hospital Association estimates that the country’s hospitals and healthcare systems lost $202.6 billion between March 1 and June 30.

UDI enforcement postponed

The U.S. Food and Drug Administration will postpone enforcing standard data formatting, Unique Device Identification (UDI) labeling, and Global Unique Device Identification Database (GUDID) data submissions for class 1 and unclassified devices (other than implantable, life-supporting or life-sustaining devices) until Sept. 24, 2022, reports the Health Industry Distributors Association.

Virtual selling: The Professional Way

Did you miss the IMDA webinar on “Virtual Selling: The Professional Way?” View it on YouTube.